Shanghai HEP Pharmaceutical Co., Ltd.
8 clinical trials · Sponsor
◉ Watch Shanghai HEP Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D (NCT07309380) | Shanghai HEP Pharmaceutical Co., Ltd. | 2026-04-01 |
| A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin (NCT04662164) | Shanghai HEP Pharmaceutical Co., Ltd. | 2025-12-01 |
| A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D (NCT06505928) | Shanghai HEP Pharmaceutical Co., Ltd. | 2024-12-11 |
| Study of Hepalatide in Chronic Hepatitis D(CHD) Patients (NCT05827146) | Shanghai HEP Pharmaceutical Co., Ltd. | 2023-10-07 |
| A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients (NCT05244057) | Shanghai HEP Pharmaceutical Co., Ltd. | 2022-08-23 |
| A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B (NCT04426968) | Shanghai HEP Pharmaceutical Co., Ltd. | 2021-06-18 |
Track Shanghai HEP Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.